Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Recs

0
Player Avatar sigeptrooper02 (91.03) Submitted: 11/22/2009 2:59:25 PM : Outperform Start Price: $1.88 IDIX Score: +395.58

spec

Featured Broker Partners


Advertisement